drugset / Trial / NCT02297100

Intravesicular Onabotulinumtoxin A in Interstitial Cystitis

NCT02297100 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to identify the optimal usage of Onabotulinumtoxin A in interstitial cystitis. Onabotulinumtoxin A, more commonly known by the trade name Botox®, is a medication that comes from the bacteria Clostridium botulinum. It works by blocking the release of the neurotransmitter acetylcholine(a chemical messenger that carries signals between nerve cells and other cells in the body). Blocking that neurotransmitter results in decreased muscle activity.

Timeline

Start
2014-12
Primary completion
2018-01-10
Completion
2018-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Other

Indications